Skip to main content
$9.90 $0.00 (0.0%)

04:00 PM EDT on 04/20/21

Forest Labs Inc (NYSE:FRX)

CAPS Rating: 3 out of 5

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter.

Current Price $9.90 Mkt Cap $371.3M
Open $9.90 P/E Ratio 1.00
Prev. Close $9.90 Div. (Yield) $0.00 (0.0%)
Daily Range $9.89 - $9.94 Volume 1,007,304
52-Wk Range $9.72 - $18.20 Avg. Daily Vol. 2,710,531

Caps

How do you think NYSE:FRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

467 Outperform
29 Underperform
 

All-Star Players

81 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:FRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Alex1963 (27.47)
Submitted January 27, 2009

This looks about $10 undervalue at &25.90 I may see if it drops a little and buy with a possible sell target of $35 or so. This was comfortably in the $35-$40 range for years before tumbling in 9/08. Very nice margins and good mgt #s. No debt. Looks… More

KevinO3826 (59.42)
Submitted October 25, 2006

Should be retracing now with divergence signals already displayed

NYSE:FRX VS S&P 500 (SPY)

Fools bullish on NYSE:FRX are also bullish on:

Fools bearish on NYSE:FRX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about FRX.

Recs

0
Member Avatar Hermanator (28.64) Submitted: 2/28/2021 7:01:20 PM : Outperform Start Price: $13.07 NYSE:FRX Score: -31.15

Good growth

Recs

0
Member Avatar radhyd (< 20) Submitted: 2/27/2021 11:07:47 AM : Outperform Start Price: $13.07 NYSE:FRX Score: -31.15

$1.1B - $1.7B estimated this year after $900M last year and this DOES NOT include MYX Bikes & Openfit Expansion. $PTON did $1.7B in 2020 & trades at a 40B market cap, $FRX could likely hit that same revenue # this year or in that range and is only 2B market cap, VERY UNDERVALUED

Recs

0
Member Avatar line70day (41.30) Submitted: 2/5/2014 12:49:52 PM : Outperform Start Price: $66.60 NYSE:FRX Score: -220.43

FRX Has lost 50% of its sales lost patent for Lexapro 2012 . Best seller Mamenda loses patent protection in 2015 . Sales & drugs launched over past three years Totaled $375 M. in 4th.Q. up 60% from a year ago. Have bought from Marck several drtgs should go a long way to over come loses

Leaderboard

Find the members with the highest scoring picks in FRX.

Score Leader

mrf00

mrf00 (< 20) Score: +452.14

The Score Leader is the player with the highest score across all their picks in FRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mrf00 < 20 12/12/2008 Underperform 3W $23.49 -57.85% +394.29% +452.14 0 Comment
milpo 39.49 11/7/2008 Underperform 1Y $23.38 -57.66% +361.47% +419.13 0 Comment
RiverRover 73.77 6/18/2009 Underperform 1Y $23.36 -57.62% +354.30% +411.92 2 Comments
GoodbyeForNow 98.13 10/9/2009 Underperform 5Y $29.56 -66.51% +286.51% +353.01 0 Comment
woNroFeybdooG 23.29 10/30/2009 Underperform 5Y $27.85 -64.45% +287.74% +352.19 0 Comment
PurePwnage 98.53 11/27/2009 Underperform 5Y $30.40 -67.43% +280.23% +347.66 0 Comment
39272x0 30.91 12/2/2009 Underperform 5Y $31.16 -68.23% +270.39% +338.62 0 Comment
Paradime 97.76 12/2/2009 Underperform 5Y $31.16 -68.23% +270.39% +338.62 0 Comment
Shizzolator 30.42 12/3/2009 Underperform 5Y $31.56 -68.63% +269.49% +338.12 0 Comment
newcommertomf 31.31 7/27/2010 Underperform 5Y $28.84 -65.67% +269.97% +335.65 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for FRX.